Introduction {#s1}
============

Compartments of eukaryotic cells are surrounded by a single- or multiple-layer lipid membrane. Both eukaryotic and prokaryotic cells also include microcompartments that are not separated from the rest of the cell by a lipid membrane (for reviews, see [@bib25]; [@bib28]). In bacteria they are surrounded by protein shells (for reviews, see [@bib31]; [@bib71]). Such microcompartments may partition metabolic pools and enzymes; therefore, they can directly affect the operation of metabolic pathways. Microcompartments may serve diverse roles, from storage of special compounds ([@bib3]), degradation of small molecules ([@bib5]), facilitation of enzyme clustering ([@bib8]), to regulating the activity of particular metabolic pathways.

The first described bacterial microcompartment was the carbon-fixing carboxysome in cyanobacteria ([@bib14]). It enables the cell to accumulate carbon dioxide (CO~2~) in the vicinity of Rubisco, which enhances the carboxylation rate. The carboxysome is an essential part of the cyanobacterial carbon concentrating mechanism (CCM). There are two types of carboxysomes, the alpha and beta carboxysome, and the structure and function of both types have been well-studied ([@bib31]). Loss of structural proteins results in carboxysome-less mutants that are unable to grow under ambient CO~2~ conditions ([@bib4]; [@bib45]; [@bib68]). Two other microcompartmentalized pathways, namely, propanediol and ethanolamine utilization, have also been experimentally explored in bacteria ([@bib10]; [@bib58]). The role of the propanediol utilization (Pdu) microcompartment in *Salmonella enterica* is the degradation of 1,2-propanediol, a product of anaerobic sugar breakdown, without the release of the degradation intermediate propionaldehyde. Propionaldehyde is toxic and, once in the cytosol, causes damage to DNA ([@bib51]). A similar role was suggested for the ethanolamine utilization (Eut) microcompartment in the detoxification of acetaldehyde produced during ethonalamine catabolism ([@bib41]). Microcompartments are also known in eukaryotes, including: metabolic compartments in liver ([@bib20]) and muscle cells ([@bib50]), and the pyrenoid in chloroplasts of green algae ([@bib23]).

Despite these discoveries, it remains challenging to determine the implications of microcompartments for cellular physiology, and to study the function of microcompartments under different conditions that may induce or suppress their formation. This task is experimentally tedious and often not feasible due to challenges in separating the microcompartments ([@bib50]). Here we present a combined experimental and mathematical approach to quantify metabolic exchange fluxes at the boundary of the pyrenoid in the chloroplast of the green alga *Chlamydomonas reinhardtii* under two environmental conditions, atmospheric CO~2~ with an active CCM; and high CO~2~, where the CCM is inactive.

Different CCMs have evolved in higher plants, algae and cyanobacteria to cope with the relatively low amounts of CO~2~ in the atmosphere (currently 0.03--0.04%) and to compensate for the low affinity of Rubisco for CO~2~ under these conditions ([@bib13]; [@bib61]). As already mentioned, CCM in cyanobacteria requires microcompartments called carboxysomes. In eukaryotic green algae, a microcompartment called the pyrenoid is crucial for the establishment of a CCM ([@bib7]; [@bib21]; [Figure 1](#fig1){ref-type="fig"}). There is no membrane or protein shell surrounding the pyrenoid which, like many of these non-membrane microcompartments (for review, see [@bib28]), was recently described as a liquid-like organelle formed by phase separation from the chloroplast stroma ([@bib19]).

![Simplified scheme of CBC cycle with and without carbon-concentrating mechanism (CCM) in *Chlamydomonas reinhardtii.*\
Under high CO~2~ conditions, no CCM is established (**A**). After exposure to ambient CO~2~, CCM is induced (**B**). As most of Rubisco and the other CBC enzymes are in the stroma under high CO~2~, most CBC flux is in the stroma (big grey circle in the stroma) and only partly involves the pyrenoid (smaller grey circle) (**A**). As most of Rubisco is inside the pyrenoid under ambient CO~2~, the CBC requires movement of selected metabolites between the stroma and pyrenoid (big grey circle) (**B**). To find out the exact differences of flux distribution between stroma and pyrenoid under these two conditions and how metabolites are exchanged between the two microcompartments were the aims of this study. Scheme adapted and simplified from [@bib6], [@bib42], [@bib65], [@bib17] and [@bib35].](elife-37960-fig1){#fig1}

Pyrenoids are known to contain Rubisco ([@bib33]; [@bib34]; [@bib38]), Rubisco activase ([@bib38]) and EPYC1, which has been proposed to be a structural protein in the pyrenoid ([@bib35]). Immunolocalisation studies showed that about 40% and 90% of the total Rubisco is located in the pyrenoid under high CO~2~ and atmospheric CO~2~, respectively, while the rest is distributed in the stroma ([@bib6]). Under ambient CO~2~ when CCM is induced, experimental evidence suggests that the inorganic carbon (C~i~, the sum of CO~2~, CO~3~^2-^, HCO~3~ and H~2~CO~3~) is actively transported across the membrane of the cell and accumulated as HCO~3~^-^ in the thylakoid lumen (for reviews, see [@bib26]; [@bib30]; [@bib43]; [@bib56]; [@bib66]). These luminal regions have highly branched tubules that reach into the pyrenoid and may facilitate movement of bicarbonate, CO~2~ and other small molecules ([@bib17]). A carbonic anhydrase (CAH3), essential for the CCM, is localized to the lumen regions that pass through the pyrenoid and is thought to catalyze the dehydration of HCO~3~^-^ to CO~2~, as the preferred form of C~i~ at the low pH of the lumen ([@bib15]; [@bib55]). The resulting CO~2~ may then diffuse back across the lumen membrane where it serves as concentrated substrate for the nearby Rubisco. A starch sheath, of unclear function, surrounds the pyrenoid, but only under ambient CO~2~ conditions ([@bib32]; [@bib48]). The starch sheath was suggested to serve as a diffusional barrier for CO~2~ and therefore potentially also larger molecules, such as metabolites, although the existing experimental evidence is inconsistent with this hypothesis ([@bib2]; [@bib63]).

What does the location of Rubisco in the pyrenoid mean for the rest of the carbon fixation pathway? The current model of CCM assumes that, apart from Rubisco, the remaining enzymes of the Calvin-Benson cycle (CBC) are situated in the stroma ([@bib30]). This implies that the substrate and product of the carboxylation reaction catalyzed by Rubisco, ribulose-1,5-bisphosphate (RuBP) and 3-phosphoglyccerate (3PGA), need to move in and out of the pyrenoid, respectively. This assumption is supported by immunolocalisation studies that failed to detect glyceraldehyde 3-phosphate dehydrogenase (GAPDH), aldolase (FBA +SBA) catalyzing the two aldol reactions of the CBC that produce fructose-1,6-bisphosphate (FBP) and sedoheptulose-1,7-bisphosphate (SBP), ribose-phosphate isomerase (RPI) or phosphoribulokinase (PRK) in pyrenoids ([@bib34]; [@bib60]). Such methods, however, are not well suited to demonstrate absence, and experimental evidence is still lacking for the localization of the remaining CBC enzymes (phosphoglycerokinase (PGK), triosephosphate isomerase (TPI), transketolase (TRK), fructose-1,6-bisphosphatase (FBPase), sedoheptulose-1,7-bisphosphatase (SBPase), and ribulose-phosphate epimerase (RPE)). Furthermore, the evidence for absence of CBC enzymes from the pyrenoid is not fully consistent as biochemical studies indicate PRK may be in close association with the pyrenoid ([@bib27]; [@bib39]). Additionally, Rubisco is differently distributed under ambient and high CO~2~ ([@bib6]) implying that the flux of the CBC that takes place in the pyrenoid may differ between these two conditions.

Our study aims to experimentally localize all CBC enzymes, and to measure Calvin-Benson cycle intermediate levels under high and ambient CO~2~. These data are then used in combination with mathematical modeling to estimate fluxes through the CBC in the stroma and the pyrenoid under these two CO~2~ conditions. Our approach allows us to determine the exchange of fluxes at the boundary of the pyrenoid and to investigate the mode of transport of the exchanged metabolites.

Results {#s2}
=======

Distribution of Calvin-Benson cycle enzymes {#s2-1}
-------------------------------------------

*C. reinhardtii* CC1690 cells were grown under low CO~2~ (LC), which fully induced the CCM ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). In addition, we obtained data from cells grown under high CO~2~ (HC), where the induction of CCM was suppressed.

*C. reinhardtii* was fractionated to provide samples enriched for stroma proteins and for pyrenoid-associated proteins according to [@bib35], followed by quantification of the abundance of enzymes involved in the CBC and starch synthesis, using either an enzymatic assay or shotgun proteomics ([Figure 2](#fig2){ref-type="fig"}, [Supplementary file 1A,B](#supp1){ref-type="supplementary-material"}). More than 61.8% of the Rubisco was found in the pyrenoid in LC grown cells, and about 21.8% in HC grown cells. Apart from GAPDH (8% in LC and 11% in HC grown cells) and PRK (13% in HC grown cells but \<2% in LC grown cells) less than 2% of the other CBC proteins were detected in the pyrenoid-enriched fractions. The \<2% of CBC proteins found in the pyrenoid-enriched fractions may represent experimental error, and resembled the distribution of phosphoglycerate mutase (PGM) and ADP-glucose pyrophosphorylase (AGPase) (0.6--1.9% in the pyrenoid [Supplementary file 1B](#supp1){ref-type="supplementary-material"}).

![Experimental data for protein distributions (outer yellow circle) and metabolite concentrations (inner blue circle) in CCM-supressed (white bars, HC) and CCM-induced (grey bars, LC for proteins and LC\* for metabolites) conditions.\
*Chlamydomonas reinhardtii* CC1690 cells were grown under high CO~2~ (HC for proteins and metabolites; white bars), ambient CO~2~ (LC for proteins; grey bars) and ambient CO~2~ bubbled for 15 min with high CO~2~ (LC\* for metabolites; grey bars). Enzyme distribution between a pyrenoid-enriched fraction (P) and a stroma-enriched fraction (S) was determined by enzyme activity measurements (Rubisco; n = 4 ± SE) and shotgun proteomics (all other proteins; n = 4 ± SE). Metabolites of the Calvin-Benson cycle (CBC) in total cells were measured by HPLC-MS/MS. The metabolite concentrations were normalized to the chloroplast volume as described in the text and [Supplementary file 1D](#supp1){ref-type="supplementary-material"}, and given as absolute concentrations (µM) in the chloroplast, which includes both microcompartments, the stroma and the pyrenoid (S + P) (n = 4 ± SE). Student´s *t*-test (alpha = 0.05), significantly changed metabolites are marked with one asterisk.](elife-37960-fig2){#fig2}

The localization of most of the CBC enzymes was further confirmed by confocal microscopy of proteins tagged with the yellow fluorescence protein Venus of cells grown under ambient CO~2~ ([@bib44]; [Figure 3](#fig3){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}). This was of particular interest as different isoforms exists for some of the CBC proteins (Rubisco small subunit, GAPDH, FBPase and aldolase). The proteins encoded by the two Rubisco small subunit genes (*RBCS1* and *RBCS2*) both showed strong localization to the pyrenoid (discussed in more details below). PGK1, GAP1, GAP3, FBA3, SBP1, RPE1, RPI1 and PRK1 proteins were located in the plastid stroma and not in the pyrenoid. While the two isoforms of GAPDH (GAP1 and GAP3) that are predicted to be localized to the chloroplast, indeed showed a strong Venus-signal in the stroma of this organelle, this was not true for the two isoforms of aldolase. The Venus-signal of FBA3 was found in the stroma but the Venus-signal of FBA2 was detected in the cytosol, in particular surrounding or confining the nucleus, indicating a role unrelated to the CBC.

![Localisation of CBC enzymes.\
*Chlamydomonas reinhardtii* CC-4533 cells expressing Venus-fusion constructs (green) were grown under ambient CO~2~, imaged by fluorescence microscopy and two pictures per constructs are shown. On the left side, solely the signal of the Venus-fusion construct (green) and on the right side, the overlay picture of the signal of the Venus-fusion construct (green) and the chlorophyll fluorescence (magenta) is shown. The white bar represents 5 µm. Details on the protein names are given in the text and [Supplementary file 2](#supp2){ref-type="supplementary-material"}.](elife-37960-fig3){#fig3}

Our pyrenoid-enrichment protocol detected 61.8% and 21.8% of Rubisco activity in the pyrenoid-enriched fraction of cells grown under LC and HC, respectively ([Figure 2](#fig2){ref-type="fig"}). The Venus-signals of the RBSC1 and RBSC2 subunits in the pyrenoid were very strong and very low in the stroma of non-dividing cells ([Figure 3](#fig3){ref-type="fig"}). The weaker stroma signal was dispersed over a much larger volume compared to the signal of the pyrenoid. Estimations by eye are therefore very difficult. [@bib35] quantified the fluorescence signal of RBSC1 and found 79% and 32% of the signal in pyrenoids in ambient-CO~2~-grown cells and high-CO~2~-grown cells, respectively. The lower values from the pyrenoid-enrichment protocol compared to fluorescence analyses might be because the pyrenoids were not completely stable during the enrichment protocol. Another possibility is that pyrenoids from dividing cells, which contain less Rubisco in their pyrenoid ([@bib19]), contributed to a higher extent to the pyrenoid-enrichment analysis than to fluorescence analyses. However, the differences between the two approaches were less than 20%, which is not large considering these are from completely different methods, different laboratories and different cultivation set-ups. For our modelling approach, we took the values of the pyrenoid-enrichment protocols shown in [Figure 2](#fig2){ref-type="fig"}, because metabolites were measured in the same cultivation set-up.

Metabolites in high-CO~2~ grown (HC) cells, and in low-CO~2~ grown cells after 15 min of exposure to 5% CO~2~ (LC\*) {#s2-2}
--------------------------------------------------------------------------------------------------------------------

Absolute quantification of the metabolites of the CBC and starch synthesis were obtained using an ion-paired liquid-chromatography coupled to triple-quadrupole mass spectrometry (HPLC-MS/MS)-based approach ([Figure 2](#fig2){ref-type="fig"}, [Supplementary file 1C](#supp1){ref-type="supplementary-material"}). As treatments necessary to separate pyrenoid from stroma would affect metabolite levels, only the total amounts of metabolite could be quantified. To convert content per cell to concentration, whole cell volume was measured by a Coulter counter (Materials and methods), and these were normalized to the chloroplast volume (31.18% of the whole cell volume) based on 3D reconstruction of EM-stacks of *C. reinhardtii* wild-type cells ([@bib54]; [Supplementary file 1D](#supp1){ref-type="supplementary-material"}). Metabolite distributions between cytosol and chloroplast were estimated based on data obtained by non-aqueous fractionation ([@bib22]; [Supplementary file 1D](#supp1){ref-type="supplementary-material"}). Measurements were carried out on cells grown and harvested in high CO~2~ (HC) and on cells grown in low CO~2~ and bubbled with 5% CO~2~ for 15 min before harvesting (LC\*). This was done to investigate differences in metabolism between CCM-induced (LC\*) and CCM-suppressed (HC) cells at comparable photosynthesis rates. This short high-CO~2~ treatment of CCM-induced cell did not change the physiology of the cells as judged from an unchanged pyrenoid structure ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). As anticipated, the rates of photosynthesis were almost equal in both sets of cells (55 and 57 µmol O~2~ \* h^−1^\* mg Chl^−1^ for HC cells and for LC\*, respectively; [Supplementary file 1E](#supp1){ref-type="supplementary-material"}). As this total flux remains the same between the two conditions, any differences in metabolite pools are likely due to physiological changes such as the altered distribution of Rubisco.

The LC\* cells showed a significant (Student's *t*-test, p-value\<0.05) decrease in 3PGA, dehydroxyactone phosphate (DHAP) and significant increases in RuBP, fructose-6-phosphate (F6P), ribose-5-phosphate (R5P), xylulose-5-phosphate (Xu5P) and ribulose-5-phosphate (Ru5P) compared to HC cells ([Figure 2](#fig2){ref-type="fig"}, [Supplementary file 1C](#supp1){ref-type="supplementary-material"}). The increased level of RuBP and increased abundance of Rubisco in the pyrenoid under LC\* provided a first indication that concentration gradient to drive diffusion or transport of RuBP into the pyrenoid may be increased in LC\* cells. However, it remains unclear if and how the fluxes of the reactions comprising the CBC were affected by the microcompartments. For example, the significant decrease of 3PGA under low compared to high CO~2~ could not be readily explained without considering a systems approach in which the effects of all participating components are jointly considered. Further, interpretation of the metabolite data needs to take into consideration the altered location of Rubisco (see above).

Modelling the effect of chloroplast microcompartmentation on the CBC {#s2-3}
--------------------------------------------------------------------

To investigate the effect of microcompartmentation on the organization and partitioning of the reaction fluxes and metabolite pools of the CBC, we devised a mathematical model tailored to *C. reinhardtii* (Materials and methods, see [Figure 4](#fig4){ref-type="fig"} for a graphical model representation and [Supplementary file 3](#supp3){ref-type="supplementary-material"} for model details). The model consists of two nominal copies of the CBC, one in the stroma and a second one in the pyrenoid, interconnected by reversible transport reactions for every CBC intermediate. We combined the model with our experimental data to ask which parts of the CBC operate in the stroma, and which in the pyrenoid. For this purpose, the volume of the stroma and the pyrenoid were needed. The volume of the stroma was determined as described above and the pyrenoid volume was calculated as the average of 12 and 10 TEM pictures of HC and LC cells of this study, respectively, applying the equation for the volume of an ellipsoid ([Supplementary file 1F](#supp1){ref-type="supplementary-material"}).

![Graphical representation of the model for carbon fixation in *Chlamydomonas reinhardtii.*\
The model includes a copy of the Calvin-Benson cycle (CBC) in the chloroplast stroma and in the pyrenoid. In addition, the model considers reversible transport between the stroma and the pyrenoid for all CBC intermediates. A complete list of enzyme and metabolite names corresponding to the given abbreviations is presented in [Supplementary file 3](#supp3){ref-type="supplementary-material"}.](elife-37960-fig4){#fig4}

All enzymatic model reactions are decomposed into their elementary reactions such that the formation of the substrate-enzyme complexes is explicitly considered (Materials and methods). The resulting structure of the model was mathematically represented by the stoichiometric matrix, $N$, where rows correspond to model components (i.e., metabolites, enzymes, metabolite-enzyme complexes) and columns correspond to reactions ([@bib46]). The entries of matrix $N$ indicated the molarity with which a component is produced (positive value) or consumed (negative value) by each reaction.

First, we sampled steady-state flux distributions, $v\left( c,k \right)$, from the flux cone, $C\left( N \right)$, given by $C\left( N \right) = \{ v\left( {c,k} \right)|N \cdot v\left( {c,k} \right) = 0$ and for every reaction $R_{i},v_{i}\left( {c,k} \right) \geq 0\}$ of the modeled system under the additional constraint of constant CO~2~ uptake (398 μM/s ), ferredoxin-NADP+ reductase (FNR, 796 μM/s) and ATPase activity (1.194 μM/s representing invariant NADPH and ATP formation. In addition, we integrated protein abundances from our experimental data on protein distribution in the chloroplast for HC and LC cells to draw conclusions on the physiologically relevant part of the flux cone (see Materials and methods) and to reduce the number of parameters which need to be estimated. The data were integrated under the assumption that the ratio of fluxes of the corresponding reactions between the stroma and the pyrenoid were bounded by the ratio of the experimentally-determined protein abundance (see Materials and methods).

Next, we described the flux through each elementary reaction, $v$, by the ubiquitous mass action kinetics ([@bib64]). According to this kinetic law, the flux through reaction $R_{i}$ was expressed by $v_{i} = k_{i}П_{j}c_{j}^{\alpha_{ji}}$, with $\alpha_{ji}$ denoting the stoichiometry with which a component (i.e. enzyme or metabolite)$j$, of concentration $c_{j}$, enters reaction $i$ as a substrate and $k_{i}$ denoted the reaction rate constant. Log-transformation of this equation yielded a system of linear equations including the log-transformed fluxes, concentrations, and rate constants. Given a steady-state flux distribution sampled from $C\left( N \right)$ the linear system could be solved using a constraint-based optimization approach (see Materials and methods) to obtain model estimates of metabolite concentrations and rate constants under the constraint that the rate constants between stroma and pyrenoid were close to each other. For reactions with known rate constants, obtained from literature, the optimization program attempted to reduce the difference between modelled $k_{i}$ and the respective literature values ([Supplementary file 4A](#supp4){ref-type="supplementary-material"}). This approach facilitated the investigation of multiple possible modes of action of the CBC based on complete sets of model parameters. The resulting model predictions provided information about: (i) the flux state most compatible to data, (ii) microcompartment-specific metabolite and enzyme concentrations and (iii) rate constants serving as proxies for enzyme turnover rates $k_{cat}$.

Due to the ambiguous experimental data, with protein abundances indicating a low but detectable GAPDH and, sometimes, PRK activity in the pyrenoid fraction but low or non-detectable Venus-signal in the pyrenoid ([Figure 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}), we inspected model predictions for three different scenarios. We considered: (*i*) activity of PRK, Rubisco and GAPDH, (*ii*) activity of PRK and Rubisco, and (*iii*) only activity of Rubisco in the pyrenoid. To further reduce the number of parameters which need to be estimated, exchange was only allowed for metabolites involved in reactions catalyzed by enzymes present in the pyrenoid. To identify the best model, we used the Chi-square statistic, $Χ^{2}$, between modelled and measured total concentration for 11 metabolites over 5,000 steady-state flux distributions ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In line with the current understanding of the CCM, where apart from Rubisco, the remaining enzymes of the CBC are hypothesized to be situated in the stroma, a significant value for $Χ^{2}$ was obtained for the scenario in which Rubisco was the only active enzyme in the pyrenoid (average Rubisco localization in pyrenoid 61.8% for LC and 21.8% for HC conditions, ${\overline{X}}_{LC \ast}^{2} = 2.20,\ {\overline{X}}_{HC}^{2} = 0.52$). A significant value was also observed when the activities of PRK (average PRK localization in pyrenoid 1.2% for LC and 12.6% for HC conditions), Rubisco and GAPDH (average GAPDH localization in pyrenoid 7.8% for LC and 11% for HC conditions) were allowed (${\overline{X}}_{LC \ast}^{2} = 0.26$, ${\overline{X}}_{HC}^{2} = 0.31$). Simulations of this latter scenario showed no activity of GAPDH in the pyrenoid, hence the good fit in the $Χ^{2}$ statistic was a result of allowing a circular transport of NADP, NADPH, BPGA and GAP. Circular transport of metabolites between stroma and pyrenoid, without metabolites being used in the pyrenoids, however, is physiologically unlikely. Under the assumption that PRK and Rubisco were active in the pyrenoid, we observed average $Χ^{2}$ values of ${\overline{X}}_{LC \ast}^{2} = 74.15,\ {\overline{X}}_{HC}^{2} = 16.51$ ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Hence, in the following, we only provide modelling results for the scenario with Rubisco as the only active enzyme in the pyrenoid.

Since we obtained at least 1000 samples with a significant fit between the modelled and measured concentrations under both experimental conditions, the presented findings rely on the parameter sets leading to the 1,000 best fits. In addition, we used the qualitative Pearson correlation coefficient to validate our predictions. We found that modelled quantities were in qualitatively excellent agreement with measurements under both conditions (Pearson correlation coefficient $\geq$ 0.99, p-value \< 10^−6^, [Figure 5](#fig5){ref-type="fig"}). Therefore, we further used this model to investigate and understand the influence of microcompartmentation on the function of the CBC.

![Comparison of metabolite data determined experimentally (Experiment) and by mathematical modelling (Model) under HC (**A**) and LC\* (**B**) conditions.\
(A + B) Modelled data is shown as white bars (n = 1,000 ± SD) and the SD-values are too small to be seen. Experimentally, metabolites were measured by HPLC-MS/MS as already shown in [Figure 2](#fig2){ref-type="fig"} (n = 4 ± SD) (grey bars).](elife-37960-fig5){#fig5}

Two modes of CBC operation {#s2-4}
--------------------------

Next, we investigated differences in thermodynamic characteristics in HC and LC\* cells. We used the modelled metabolite concentrations and equilibrium constants, $K_{eq},$ obtained from eQuilibrator ([@bib18]) to estimate $\Delta G = - RT\  \ast \ \left( {ln\ K_{eq}\  - \ ln\ Q} \right)$ for each reaction across the sampled flux distributions, where $Q$ is the ratio of active product concentrations and active reactant concentrations. In LC\* cells (CCM-induced) we found TRK to be the only enzyme operating in both directions ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). For the remaining enzymes, except RPE and RPI for which $\Delta G > 0$, the reactions were predicted to be exergonic (i.e., $\Delta G < 0$,). The positive $\Delta G$ for reactions RPE and RPI may point to a substrate channeling ([@bib11]). We observed a change in sign of $\Delta G$ between the two conditions for enzyme TPI only ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

In addition, we studied the function of the CBC at the level of reaction fluxes. We compared the net flux, corresponding to the sum of fluxes of forward and backward reaction in case of reversible reactions for the HC and LC\* cells (see [Figure 6A](#fig6){ref-type="fig"} for the fold-changes between the HC and LC\* fluxes, see [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} for the fluxes at HC and LC\* separately, [Supplementary file 5](#supp5){ref-type="supplementary-material"} and [6](#supp6){ref-type="supplementary-material"}). Under the assumption that the rate of CO~2~ uptake from the environment was the same in HC and LC\* cells, the modelled rate of CO~2~ diffusion into the pyrenoid for LC\* cells showed a three-fold increase in comparison to HC cells, indicating that the model captures the function of the CCM ([Figure 6B](#fig6){ref-type="fig"}). The rate of the Rubisco reaction in the pyrenoid followed the CO~2~ import into the microcompartment and was, therefore, three-fold increased under LC\* conditions. Since the function of Rubisco depends not only on the import of CO~2~, but also on the availability of RuBP, its predicted rate of import into the pyrenoid from the stroma was also three-fold increased in LC\* cells. In addition, the rate of 3PGA export from the pyrenoid into the stroma was higher under LC\* conditions than in HC conditions.

Mechanisms of metabolite transport between microcompartments {#s2-5}
------------------------------------------------------------

To examine the mode of transport between pyrenoid and stroma, the bound and free metabolite levels were determined for both conditions ([Figure 6C](#fig6){ref-type="fig"}, [Supplementary file 5B](#supp5){ref-type="supplementary-material"} and [6B](#supp6){ref-type="supplementary-material"}). Due to elementary reactions considered in modelling (Materials and methods), we modelled concentrations for free metabolites as well as concentrations for the respective metabolite-enzyme-complexes. In case a metabolite can bind multiple enzymes, the concentration of the bound metabolite was given by the sum of concentrations over the respective enzymes. The model predicted that the vast majority of the RuBP was bound. The observed increase in RuBP concentration for LC\* cells was therefore mainly due to an increase in bound RuBP in the pyrenoid as a result of an increased Rubisco concentration ([Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}). The model predicted slightly higher free RuBP in the stroma in comparison to the pyrenoid (0.024 µM and 0.008 µM difference under LC\* and HC conditions, respectively). Furthermore, in line with increased transport RuBP rates into the pyrenoid, the difference between free RuBP in the stroma and pyrenoid was larger in LC\* than HC cells. Since in both cell types we observed a concentration gradient in the direction of RuBP transport towards the pyrenoid, the model predictions indicate diffusion or facilitated transport may be a feasible mechanism of RuBP transport under HC and LC\* (although the estimated concentration gradient is very small). In contrast, the model predicted equal free amounts of 3PGA between pyrenoid and stroma under HC and LC\*, implying diffusional equilibrium.

Discussion {#s3}
==========

Quantitative and qualitative experimental data were obtained for the distribution of CBC and starch synthesis pathway enzymes between the chloroplast stroma and the microcompartment pyrenoid, confirming that Rubisco is largely located in the pyrenoids (average Rubisco localization in pyrenoid 61.8% for LC and 21.8% for HC conditions). All other CBC enzymes were present at only very low amounts (PRK, GAPDH) or were totally absent from the pyrenoid in LC cells with an operational CCM. Metabolite data measured in whole cells revealed that LC\* cells have altered CBC metabolite levels to those in HC cells at the same CO~2~ concentration and net rate of photosynthesis. However, this data alone is not sufficient to understand flux between the stroma and pyrenoid.

A kinetic model, parametrizing each reaction in the stroma and pyrenoid, allowed us to calculate flux distributions under the two distinct physiological states. The validation of the model indicated statistically significant quantitative and qualitative agreement between the experimental and modelled chloroplast metabolite concentrations. The fit for the model as a whole was assessed, considering the contribution of the predictions for each metabolite level. The agreement between experimental data and predicted metabolite levels was statistically acceptable for 10 out of 16 individual metabolites. In the case of GAP and SBP, the lack of statistical fit could be due to the fact that these compounds are involved in redox-regulated reactions, namely the reduction of BPGA to GAP catalyzed by GADPH ([@bib57]) and the hydrolysis of SBP catalyzed by SBPase ([@bib16]). The values given by the model are lower than the experimental pool sizes implying that there might be incomplete redox activation. This discrepancy is in line with the fact that the model does not include redox regulation. This explanation is supported by the observation that the applied light intensity of 46 μmol photons\*m^−2^\*s^−1^ is not saturating, and analysis of SBP and S7P indicated that SBPase is incompletely activated at this light intensity ([@bib40]). For the reaction catalyzed by GAPDH, it is likely that NADPH provided by the light reaction was rate limiting rather than GAPDH redox activation ([@bib40]).

To provide further validation of the model, we compared the predicted rate constants with values for k~cat~ available from literature that were not used in the model parameterization (Materials and methods; [Supplementary file 4A](#supp4){ref-type="supplementary-material"}). This was the case for TRK (Xu5P, rate constant = 37 \* s^−1^; Ru5P, rate constant = 37 \* s^−1^) ([Supplementary file 4B](#supp4){ref-type="supplementary-material"}) for which the published k~cat~ values in spinach are \<0.02 \* s^−1^ for Xu5P and Ru5P ([@bib62]). The values for the plant TRK reported in literature are surprisingly low, since those in yeast (k~cat~ = 113 \* s^−1^) and human (k~cat~ = 9 \* s^−1^) ([@bib1]) are much higher.

The first important output of the model included the fluxes of the exchange reactions between the pyrenoid and the stroma. The mathematical model enabled us to calculate exchange fluxes between chloroplast stroma and pyrenoid based on enzyme partitioning, rate constants of enzymatic reactions and steady-state metabolite levels. The model predicted an increase in the flux of the Rubisco reaction inside the pyrenoid under LC\* compared to HC conditions. This prediction reflects the increased presence of Rubisco in the pyrenoid under these conditions. The model also predicted import of RuBP and export of 3PGA into and from pyrenoid, respectively, with both fluxes being higher under LC\* compared to HC conditions. The concentration gradient for RuBP between stroma and pyrenoid was larger under LC\* than under HC, but for both conditions the concentration gradients were small (0.024 µM and 0.008 µM, respectively). In case of 3PGA, the model predicted, for both conditions, that there is no concentration gradient between stroma and pyrenoid. Since there is no accumulation of RuBP in the pyrenoid or 3PGA in the stroma, active transport seems unnecessary and movement between the microcompartments may occur by diffusion.

Previously, the starch sheath surrounding the pyrenoid under ambient but not under high CO~2~ conditions, was suggested to work as diffusional barrier to prevent CO~2~ from diffusing out of the pyrenoid ([@bib2]). In this case, the starch sheath would also represent a diffusional barrier for RuBP entering into the pyrenoid. In the model, such an increased diffusional barrier could be seen as a change in the diffusion constant between HC, where no starch sheet was present, and LC\*, where a starch sheet was established. The diffusion constants is proportional to 10.623 s^−1^ (86.664 µM s^−1^ \* 0.008158^−1^ µM^−1^) and 10,259 s^−1^ (246.12 µMs^−1^ \* 0.02399^−1^ µM^−1^) for HC and LC\*, respectively ([Figure 6A](#fig6){ref-type="fig"}, [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}), revealin [Figure 6---figure supplement 1g](#fig6s1){ref-type="fig"} that the difference in the diffusion constants was minor. Therefore, our model does not support the idea of an increased diffusional barrier between pyrenoid and stroma under LC\* for RuBP. This finding is experimentally supported by the fact that a starch-less mutant, also lacking the starch sheath around the pyrenoid, is still able to develop a fully functional CCM ([@bib63]).

![Changes in estimated reaction fluxes and metabolite concentrations for HC and LC\* *Chlamydomonas reinhardtii* cells.\
(**A**) Fold changes of model predicted average net flux (represented by arrows) and total metabolite concentrations (represented by circles) between LC\* and HC cells indicated by a colour code (see legend) and size of the arrows. The actual values are provided in [Supplementary file 5](#supp5){ref-type="supplementary-material"} and [6](#supp6){ref-type="supplementary-material"} and summarized in [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}. The main difference observed between HC and LC\* conditions was an increased flux through Rubisco in the pyrenoid and an increased flux of RuBP and 3PGA to the pyrenoid and from the pyrenoid, respectively. The flux through the Calvin-Benson cycle located in the stroma, however, is similar under both conditions (fold change of 1). (**B**) Net flux for transport of CO~2~, RuBP and 3PGA between stroma and pyrenoid under HC (orange) and LC\* (blue) conditions. A positive value indicates transport from stroma to pyrenoid, while a negative value indicates transport from pyrenoid into stroma. (**C**) Concentrations of bound and free RuBP and 3PGA under HC (orange) and LC\* (blue) conditions.\
Figure 6---source data 1.Summary of the most important concentrations and fluxes.](elife-37960-fig6){#fig6}

As the fluxes of both 3PGA and RuBP are increased under LC\* compared to HC with minor (RuBP) or no (3PGA) increase in the concentration gradients, flux is increasing with minor or no change in the driving force. This implies that instead of a strong diffusional boundary there may be facilitated diffusion under LC\* compared to HC. Recently, several proteins that are known to be expressed under low CO~2~ conditions but are of unknown function were sub-cellularly localized ([@bib36]). LCIC/LCIB and LCI9 are expressed in the proximity of the starch sheath and surrounding the pyrenoid, which is consistent with one or several of these proteins being involved in facilitating diffusion of RuBP into and of 3PGA out of the pyrenoid. This would occur exclusively under low CO~2~ conditions, as the according genes are only expressed under low CO~2~ ([@bib69]; [@bib70]). Recently it was suggested that LCIC/LCIB most likely has a carbonic anhydrase activity ([@bib29]), but additional functions are still possible.

A high resolution cryoEM study of the *C. reinhardtii* chloroplast ([@bib17]) revealed the presence of pyrenoid minitubules that form narrow continuous channels between the inter-thylakoid stromal space and the pyrenoid matrix. One function of these minitubules could be to facilitate diffusion of RuBP and 3PGA, apart or in addition to the protein candidates mentioned above. The estimated minitubule lumen diameter is of the order of 3--4 nm by 8--15 nm, which is not much larger than the longest axes of RuBP and 3PGA (about 1.2 nm and 0.7 nm, respectively), so diffusion of these metabolites in the minitubules would be possible. It will be interesting to learn if the physiochemical properties of these minitubules favor facilitate diffusion of these metabolites, either as free acids or as the magnesium complexes that are likely to predominate at pH and magnesium concentration found in the stroma in the light ([@bib47]; [@bib67]). Charge properties might, speculatively, provide a means to discriminate between CBC intermediates and the weakly anionic bicarbonate and neutral CO~2~.

Under low CO~2~ conditions and a fully functional CCM, the limiting Rubisco substrate CO~2~ is concentrated in the pyrenoid. Moreover, our data indicate that the CCM also establishes structures that allow facilitated transport of RuBP, the other Rubisco substrate, from the stroma to the pyrenoid and the release of the Rubisco product 3PGA into the stroma, where the rest of the CBC enzymes are located. Such channels for exchange of CBC metabolites were suggested to be present in the pyrenoid of *C. reinhardtii* ([@bib17]) and the proteinaceous shell of the carboxysome based on the number of shell proteins and their localization in the shell ([@bib31]). However, supporting experimental data to our knowledge is scarce so far and therefore our study is the first with underlying experimental metabolite data postulating such transport reactions in a carbon-concentrating microcompartment.

Altogether, our systems biology approach allowed us to demonstrate (*i*) that changes in microcompartments cause specific inhomogeneities that affect steady-state metabolite levels and have to be considered in mathematical modelling approaches based on such experimental data; (*ii*) that mathematical models with mild assumptions can be used to study flux distributions between reactions inside and outside microcompartments, which are very difficult and often technically impossible to study experimentally; and (*iii*) that metabolites can be identified that are exchanged between the compartments and their exchange fluxes quantified. Our study opens the possibility to investigate the effects of microcompartmentation in different cellular scenarios and to understand their role in the overall physiology of the investigated system.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\       Designation          Source or\                                                                                           Identifiers                                                      Additional\
  (species) or\                            reference                                                                                                                                                             information
  resource                                                                                                                                                                                                       
  ------------------- -------------------- ---------------------------------------------------------------------------------------------------- ---------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain, strain\     CC1690 wild-type\    Chlamydomonas\                                                                                       RRID:[SCR_014960](https://scicrunch.org/resolver/SCR_014960)     
  background\         strain               Resource Center                                                                                                                                                       
  (*Chlamydomonas*\                                                                                                                                                                                              
  *reinhardtii*)                                                                                                                                                                                                 

  Strain, strain\     CC-4533 wild-type\   Chlamydomonas\                                                                                       RRID:[SCR_014960](https://scicrunch.org/resolver/SCR_014960)     \-
  background\         strain               Resource Center                                                                                                                                                       
  (*Chlamydomonas*\                                                                                                                                                                                              
  *reinhardtii*)                                                                                                                                                                                                 

  Antibody            rabbit Anti-\        AgriSera                                                                                             Cat\# AS11 1737;\                                                (1:7500)
                      Beta-CA1                                                                                                                  RRID:[AB_10752086](https://scicrunch.org/resolver/AB_10752086)   

  Antibody            rabbit Anti-AtpD     AgriSera                                                                                             Cat\# AS10\                                                      (1:30000)
                                                                                                                                                1590;\                                                           
                                                                                                                                                RRID:[AB_10754669](https://scicrunch.org/resolver/AB_10754669)   

  Software,\          MaxQuant             MaxQuant ([http://www.biochem.mpgde/5111795/maxquant](http://www.biochem.mpg.de/5111795/maxquant))   RRID:[SCR_014485](https://scicrunch.org/resolver/SCR_014485)     version 1.5.2.8
  algorithm                                                                                                                                                                                                      

  Software,\          Codes used\                                                                                                                                                                                The mathematical models can be accessed via <https://github.com/ankueken/Chlamy_model> (copy archived at <https://github.com/elifesciences-publications/Chlamy_model>).\
  algorithm           for modelling                                                                                                                                                                              
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cell growth {#s4-1}
-----------

*Chlamydomonas reinhardtii* CC1690 wild-type strain ([@bib49]) was obtained from the Chlamydomonas Resource Center (RRID:[SCR_014960](https://scicrunch.org/resolver/SCR_014960)) and cultivated as described in [@bib40]. Cells were growth photoautotrophically in a 5-litre bioreactor BIOSTATB-DCU (Sartorius Stedim, Germany) for five days until a cell density of 3--5\*10^6^ cells\*ml^−1^ was reached and thereafter, turbidity was kept constant. The culture in the bioreactor was constantly stirred with 50 rpm at 24°C, exposed to an average of 46 μmol photons\*m^−2^\*s^−1^ (measured internally at four different positions) and bubbled at a rate of 400 ccm with air enriched with 5% CO~2~. Turbidity was kept constant by medium exchange (125 ml\*h^−1^) for two days before harvesting the high-CO~2~-grown cells. Then the air bubbling of the bioreactor was changed from 5% CO~2~ to ambient air. Cells were adapted to the low-CO~2~ conditions for 30 hr. Turbidity was kept constant by medium exchange (39 ml\*h^−1^) and CO~2~ in the outlet air of the bioreactor was measured ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The CO~2~ level measured by gas chromatography in the outlet air of the bioreactor dropped within 12 hr from 4.5% (bubbling with 5%) to a constant 0.02% (bubbling with air of approximately 0.039% CO~2~). Levels inducing CCM (0.1%) were already reached after 4 hr but the system needed at least an additional 8 hr to equilibrate at 0.02% CO~2~. We can therefore assume that cells in the bioreactor are exposed to, at a maximum, 0.02% CO~2~. LC cells were harvested after 30 hr of bubbling with ambient air and LC\* cell after an additional 15 min bubbling with air enriched with 5% CO~2~. Cell number and cell volume were determined by a Z2 Cell Coulter (Beckman Coulter, USA) in triplicates of 100-fold diluted samples.

Cell harvesting {#s4-2}
---------------

Before harvesting, 500 ml of, both, the high- and the low-CO~2~-grown cells were transferred to a 1 L glass bottle and kept at the same light intensity (46 μmol photons\*m^−2^\*s^−1^, measured internally as indicated above) as in the bioreactor, stirred and bubbled with ambient (LC) or 5% CO~2~ (HC and LC\*) for 15 min. For metabolite measurement, the cells were quenched with 70% cold methanol as described in [@bib40]. For enzyme activities and proteomics experiments, 10 ml of cells were spun-down at 4000 rpm for 2 min at 4°C and stored at −80°C before usage.

Metabolite measurements by HPLC-MS/MS {#s4-3}
-------------------------------------

Polar metabolites were extracted with chloroform/methanol/water, separated with an ion-paired liquid chromatography and detected on a triple quadrupole as described in [@bib40]. The absolute amounts of metabolites measured by HPLC-MS/MS were normalized to the cell volume determined by a Coulter counter described above. The metabolite levels were then normalized to the chloroplast volume according to [@bib54] using distributions between cytosol and chloroplast according to [@bib22]. See [Supplementary file 1D](#supp1){ref-type="supplementary-material"} and the Result section for more details.

Enzymatic activities {#s4-4}
--------------------

The ten ml algal material was defrosted on ice and extracted with extraction buffer (EB) containing 2% Triton (50 mM HEPES, 20 μM leupeptin, 500 μM DTT, 1 mM PMSF, 17.4% glycerol). The samples were sonicated 3 × 15 s (six cycles, 50% intensity, Sonoplus Bandelin electronics, Germany) and kept on ice in between for 90 s. Half of the sample was then used for analysis of total enzyme activity and half was centrifuged at 14000 rpm for 2 min to obtain a soluble and pellet fraction. The pellet was washed twice with 500 μl EB before resuspension in 500 μl EB. The enzyme activities of total, soluble and pellet fraction were analyzed together in 96 well microplates using a Janus pipetting robot (Perkin-Elmer, Belgium) and absorbances were determined using a Synergy, an ELX-800 or an ELX-808 microplate reader (Bio-Tek, Germany). For each enzyme three different dilutions of each algal sample were measured (final concentrations in assay were 1:60, 1:300, 1:600). The AGPase ([@bib24]), PGM ([@bib37]) and Rubisco ([@bib59]) enzymatic assay were performed as described previously. For Rubisco activity measurement, the assay length was adjusted to 30--60 min.

Proteomics data {#s4-5}
---------------

The soluble and pellet fractions described above were subjected to shotgun proteomics analysis as described in [@bib35]. Data analysis was done using the MaxQuant Software (RRID:[SCR_014485](https://scicrunch.org/resolver/SCR_014485); [@bib12]).

Protein localization {#s4-6}
--------------------

Proteins were tagged and sub-compartmentally localized as described in [@bib36]. Briefly, for the fluorescence protein tagging, open reading frames of CBC genes were PCR amplified (Phusion Hotstart II, Thermo Fisher Scientific, U.S.A.) from genomic DNA, gel purified and cloned in-frame with a C-terminal Venus-3xFLAG (pLM005) tag ([@bib35]) by Gibson assembly. Junctions were Sanger sequenced and constructs were linearized by either EcoRV or DraI prior to transformation into WT *C. reinhardtii* (CC-4533). For transformation by electroporation, 14.5 ng kbp-1 of cut plasmid was mixed with 250 μL of 2 × 10^8^ cells mL^−1^ at 16°C in a 0.4 cm gap electroporation cuvette then transformed using a Gene Pulser II (Bio-Rad Laboratories, U.S.A.) set to 800V and 25uF. Transformed cells were selected on Tris-acetate-phosphate (TAP) paromomycin (20 μg mL-1) plates and maintained in low light (5--10 μmol photons m^−2^ s^−1^) until screening for fluorescence using a Typhoon Trio fluorescence scanner (GE Healthcare, U.S.A.).

For confocal microscopy, Venus-tagged lines were grown photoautotrophically in Tris-phosphate (TP) liquid medium in air (ambient CO~2~) at 150 μmol photons m^−2^ s^−1^ light intensity. 15 µL of cells at \~2--4×10^6^ cells mL^−1^ were pipetted onto poly-L-lysine coated plates (Ibidi) and overlaid with 120 µL of 1% TP low-melting-point agarose at \~34°C to minimize cell movement. Images were acquired using a spinning-disk confocal microscope (Leica DMI6000, Leica Microsystems, Germany). Venus signal was detected by 514 nm excitation with 543/22 nm emission and chlorophyll using 561 nm excitation with 685/40 nm emission. Images were analyzed using Fiji ([@bib53]).

Model description {#s4-7}
-----------------

The model was constructed to simulate carbon fixation in the chloroplast under different CO~2~ availability. The model included two compartments: (*i*) the chloroplast stroma and (*ii*) the pyrenoid, a microcompartment located inside the chloroplast associated with the operation of a CCM. The postulated function of the pyrenoid is to generate a CO~2~-rich environment around the photosynthetic enzyme Rubisco ([@bib33]; [@bib34]). During carbon fixation Rubisco catalyses the production of two molecules 3PGA from RuBP and CO~2~. Moreover, it catalyses the first reaction of the photorespiratory pathway: the reaction of RuBP and oxygen (O~2~) to 3PGA and 2-phosphoglycolate. The model, however, did not include this reaction since under the high CO~2~ conditions, this reaction was very likely suppressed ([Supplementary file 1E](#supp1){ref-type="supplementary-material"}).

To investigate the role and interplay of the pyrenoid and the CBC we included two full copies of the CBC, one in the chloroplast stroma and one in the pyrenoid. The copies of the CBC were linked by reversible transport reactions for all CBC intermediates. The enrichment of CO~2~ in the pyrenoid (CCM) can be achieved via diffusion of CO~2~ from the stroma into the pyrenoid. A full list of model reactions and components is presented in [Supplementary file 2](#supp2){ref-type="supplementary-material"}.

Model construction {#s4-8}
------------------

The model simulated carbon fixation on the chloroplast level and included 62 reactions distributed over the chloroplast stroma and the pyrenoid. To compare the simulated data and experimentally determined enzyme parameters, each reaction was modelled by its elementary reaction steps. More specifically, given an irreversible reaction $\left. A\rightarrow B \right.$ catalyzed by enzyme $E$, the model included three elementary reactions: $\left. A + E\leftrightarrow AE \right.$ and $\left. AE\rightarrow B + E. \right.$ For reversible reactions $\left. C\leftrightarrow D \right.$ the model includes six elementary reactions $\left. C + E\leftrightarrow CE \right.$, $\left. CE\rightarrow D + E \right.$, $\left. D + E\leftrightarrow DE \right.$ and $\left. DE\rightarrow C + E. \right.$

After splitting of reactions the model consists of 226 irreversible reactions and 128 components (metabolites, enzymes, enzyme-substrate complexes). Each CBC copy, thereby, comprised 65 elementary reactions linked by 40 irreversible diffusion reactions. Moreover, the model included eight irreversible reactions transporting triose-phosphates from the stroma into the cytosol and vice versa, ATPase reaction converting ADP to ATP and a simplified ferredoxin-NADP + reductase (FNR) reaction converting NADP to NADPH. The production of NADPH and ATP were calculated from the measured production of oxygen, assuming two molecules of NADPH produced per oxygen molecules and 1.5 ATP molecules per NADPH molecule ([Supplementary file 1G](#supp1){ref-type="supplementary-material"}).

The underlying system of ordinary differential equations (ODE), therefore, simulated a system of $n = 226$ reactions acting on $m = 128$ model species and was formulated as $\frac{dc_{i}}{dt} = \sum\limits_{j = 1}^{m}n_{ij}v_{j}$, where $v_{j}$ was the flux trough reaction $j$ and $n_{ij}$ the respective stoichiometric coefficient in the stoichiometric matrix $N$, indicating the molarity with which substrate $i$ enters reaction $j$. The ODE system was used to simulate the steady-state concentrations $c$ of all model species under different environmental conditions by solving $\frac{dc_{i}}{dt} = \sum\limits_{j = 1}^{m}n_{ij}v_{j} = 0$. The reaction flux $v\left( c,k \right)$ depended on species concentrations $c$ and reaction rate constants, $k$, and is calculated using the law of mass-action. Thus, the flux through an irreversible reaction $j$ was given by $v_{j}\left( {c,k} \right) = k_{j}\prod\limits_{i}c_{i}^{n_{ij}^{-}}$, where $n_{ij}^{-}\, = \, - n_{ij}\, if\, n_{ij}\, < \, 0$ and 0, otherwise.

Model parameterization {#s4-9}
----------------------

Here, we describe the procedure of determining parameter values for $c$ and $k$ for sampled flux distributions, $v$.

To guarantee a steady state, we first sampled steady-state flux distributions with the COBRA Toolbox ([@bib52]) function *sampleCbModel* by sampling solutions of the linear program in ([Equation 1](#equ1){ref-type="disp-formula"}). To obtain flux distributions leading to a high quality fit between simulated and measured data and to reduce the number of parameters which need to estimated, we integrated the measured enzyme distribution between stroma and pyrenoid, whereby the flux ratio between pyrenoid and stroma for a reaction catalyzed by enzyme $E$ follows the measured ratio of protein abundance. Therefore, we sampled flux distributions from the solution space of the following linear program:$$\begin{matrix}
{Nv = 0} \\
{v_{pyrenoid} = q\left( {v_{stroma} + v_{pyrenoid}} \right)} \\
{v^{FNR} = 796} \\
{v^{ATPase} = 1.194} \\
{v^{CO2\ uptake} = 398} \\
{0 \leq v \leq v_{max}} \\
\end{matrix}$$

Consequently, if $e_{pyrenoid} = q(e_{stroma} + e_{pyrenoid})$, where $e$ was the measured relative enzyme activity or if available amount, then $v_{pyrenoid} = q(v_{stroma} + v_{pyrenoid})$. While $q$ was chosen uniformly at random for each sampled flux distribution from the measured range. For enzymes with measured relative activity in the pyrenoid below 5%, we considered only the enzyme located in the stroma to be active. In addition, based on experimental data we fixed the rate of CO~2 ~uptake to $398\ \mu M/s$. As upper limit of flux through a reaction we used $v_{max} = 1,000\ \mu M/s$. Moreover, we fixed the flux through RNR and ATPase to constant values estimated from experimental data since light intensity was unaltered.

For each flux distribution $v^{\ast}$ obtained from sampling, we determined species concentrations $c$ and reaction rate constants $k$ leading to the respective flux distribution under mass-action kinetics by solving the program in [Equation 2](#equ3){ref-type="disp-formula"}:$$\min{\varepsilon^{+} + \varepsilon^{-}}$$$$\forall_{j = 1:n}$$$${\log v_{j}^{*}} = {\log k_{j}} + {\sum\limits_{i = 1}^{m}n_{ij}^{-}}{\log c_{i}}$$$$\log k_{pyrenoid} - \log k_{stroma} + \varepsilon^{+} = 0$$$${\log k_{pyrenoid}} - {\log k_{stroma}} - \varepsilon^{-} = 0$$$${\log{k_{min} \leq {\log k} \leq}}{\log k_{max}}$$$${\log{c_{min} \leq {\log c} \leq}}{\log c_{max}}$$$$\varepsilon^{+} \geq 0,\varepsilon^{-} \geq 0.$$

The lower bounds for the free concentrations of metabolites other than RuBP, BPGA and 3PGA in the linear program in Equation 2 were set to 90 and 99% to ensure agreement with the experimental data on the total metabolite levels. The lower bound for 3PGA were set to 50% of measured total concentration, while for RuBP and BPGA generic lower bounds of $c_{min_{i}}$ = 0.01 μM were used. The upper bounds for all free metabolite concentrations were set to 100% of the measured total concentration.

Since we assumed that $k$ depends not only on environmental parameter, like temperature and pressure, but also includes regulation, which cannot be integrated in mass-action kinetics (e.g., allosteric regulation), we asked for the minimum difference in $k$ between pyrenoid and stroma leading to a feasible solution of the program. For reactions with known enzymatic turnover obtained from BRENDA ([@bib9]; [Supplementary file 3](#supp3){ref-type="supplementary-material"}), we integrated this information by restricting the respective parameter boundaries. Since the model provides subcompartment-specific estimates of metabolite concentrations, we considered the sum of the respective stroma and pyrenoid metabolite concentrations and compared them to the estimated and measured metabolite concentrations in the chloroplast. We then determined the goodness-of-fit for each set of simulated metabolite concentrations and enzyme distribution and rank the parameter sets based on their chi-square value considering the 1,000 top ranked for further investigation.

Net flux calculation {#s4-10}
--------------------

In case of non-enzymatic reactions of form $A\begin{matrix}
\overset{v_{f}}{\rightarrow} \\
\underset{v_{b}}{\leftarrow} \\
\end{matrix}B$ the reported net flux was calculated as $v_{f} - v_{b}$. Since the activity of an enzyme is given by the rate of product formation per unit of time, we consider reaction flux $v_{cat}$ as net flux for an irreversible reaction catalyzed by enzyme $E$ with elementary reactions $A + E\begin{matrix}
\overset{v_{f}}{\rightarrow} \\
\underset{v_{b}}{\leftarrow} \\
\end{matrix}AE$ and $AE\ \overset{v_{cat}}{\rightarrow}B + E$. In case of reversible enzymatic reactions modelled by elementary reactions $C + E\begin{matrix}
\overset{v_{f1}}{\rightarrow} \\
\underset{v_{b1}}{\leftarrow} \\
\end{matrix}CE$, $CE\overset{v_{cat\_ f}}{\rightarrow}D + E$, $D + E\begin{matrix}
\overset{v_{f2}}{\rightarrow} \\
\underset{v_{b2}}{\leftarrow} \\
\end{matrix}DE$ and $DE\overset{v_{cat\_ b}}{\rightarrow}C + E$, we consider $v_{cat\_ f}$−$v_{cat\_ b}$ as reported net flux.
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Thank you for submitting your article \"Effects of microcompartmentation on flux distribution and metabolic pools in *Chlamydomonas reinhardtii* chloroplasts\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Ian Baldwin as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This work begins the process of understanding how cellular compartmentalization is playing mediating the flux balance of a biochemical system.

Essential revisions:

1\) There are issues surrounding the potential localization and quantification of this partitioning for Rubisco that need to be discussed/tested depending on how the study was conducted.

2\) Better clarity on how fractional metabolite levels were estimated.

3\) There was concern that the lack of allosteric factors in the model was creating the lack of fitting on specific metabolites. This potential hindrance of the model should be discussed and the potential role of this in limiting the model fit should be commented upon.

*Reviewer \#1:*

The current manuscript addresses an important issue of green algal cell biology, the distribution of enzymes of the Calvin Benson cycle and metabolites within microcompartments of the chloroplast (pyrenoid, stroma) as well as their dependence on high and ambient CO~2~ concentrations. These data are the basis for modeling approaches. The model predicts that the substrate and end product of Rubisco diffuse in and out of the pyrenoid with higher fluxes in cells with ambient CO~2~ levels.

The authors measure Rubisco activity in fractions enriched in pyrenoid and stromal proteins and find differences in the activity in both fractions that change in their ratio, depending on the CO~2~ level (Figure 2). The authors write that more than 60% of Rubisco is in the pyrenoid in LC cells (ambient CO~2~ level) and about 20% in HC cells (5% CO~2~ level). Then, they perform immunolocalization studies with Venus-fusion constructs (Figure 3). To my mind, the results shown in Figure 3 contradict the former findings of the authors. The small Rubisco subunits *RBCS1* and *RBCS2* are only visible in the pyrenoid and not in the other parts of the chloroplast, including the stroma. Unfortunately, the authors do not mention if the used cells were grown under LC or HC for these experiments. In any case, a certain portion of Rubisco should be distributed over the chloroplast stroma if Rubisco is present to a significant extent in the stroma, and the results are not an artifact of an impure stromal fraction. The stromal fraction was obtained by lysis of the cells and a centrifugation step using the resulting supernatant. I am afraid that this fraction may be contaminated with pyrenoid proteins that derive from partial lysis of the pyrenoid when disrupting the cells. Figure 1A in Mackinder et al. (2016), to which the authors refer, shows parts of pyrenoids as well, being in agreement with this possibility. An alternative would be that the fusion construct is not reflecting the real localization pattern of the smaIl Rubisco subunits. I suggest that the authors clarify this important step by conducting immunolocalization experiments with cells grown at LC and HC using anti-Rubisco antibodies before they draw their final conclusions. Especially under HC, it should be visible that the Rubisco is not only present in the pyrenoid but also in the rest of the plastid.

Another critical point is that the authors change the CO~2~ treatment conditions when performing the metabolites studies. In the latter case, they use LC cells that have been treated for 15 min with 5% CO~2~ before harvesting. Their reasons are understandable, but it would be desirable to have the same conditions for the protein and metabolites studies.

In summary, this is an interesting and highly important topic and the manuscript should be of interest to a broad readership. However, the authors have to address the mentioned concerns to either verify their conclusion or to change it and consequently adapt their model.

*Reviewer \#2:*

This is a very exciting manuscript detailing the distribution of many enzymes found in the chloroplast of *Chlamydomonas reinhardtii*. The authors are mainly focused on the location of the Calvin-Benson cycle (CBC) enzymes and whether a specific protein is in the pyrenoid or chloroplast stroma and whether they moved if the cells had a functioning CCM or not. They clearly demonstrate the localization by measuring enzymatic activity after fractionation, using an MS-based method on chloroplast fractions to quantitate protein abundance and using fluorescently tagged proteins to visualize their location (Figure 3). This work is solid and the conclusions are well considered.

The authors then go on to estimate the metabolite concentrations of a number of CBC intermediates and model metabolite fluxes between the stroma and pyrenoid. This is difficult to address experimentally but this work is the best estimation of the metabolite fluxes and concentrations to date. The fact that the estimated pyrenoid and stromal concentrations of RuBP and PGA are similar is very interesting.

In my opinion the authors should address two issues near the beginning of the Discussion. The most serious issue relates to the estimation of metabolite concentrations. If I understand the methods correctly, the authors have quantitated the metabolite amount in the entire cell and have not tried to determine the metabolite amounts in the chloroplast versus cytoplasm. If that is true, it is not clearly stated in the beginning of the Discussion. How were chloroplast CBC metabolite levels estimated if the measured amount of each metabolite was for the entire cell? The authors need to say exactly what assumptions they used to calculate the amount of the metabolite in the stroma. The only place this was addressed was in the legend to Figure 2. It should be in the Materials and methods section and reiterated at the beginning of the discussion.

My second concern was which value for the percentage of Rubisco in the pyrenoid was used? Clearly the 60% pyrenoid localization seen in fractionation is lower than earlier estimates using immunogold or the fluorescence measurements. Again at the beginning of the model description and in the discussion the actual values used should be stressed. From Figure 1 it would appear that the value used was 100% in the pyrenoid but I am not certain. I think any value over 90% is reasonable but the authors should state why they favored the fluorescence method or literature values over the MS or activity measurements. I suspect there is some dissolution of the pyrenoid and that is what accounts for the discrepancy but it should be noted.

*Reviewer \#3:*

This manuscript examined the localisation of all enzymes involved in the CB cycle in *Chlamydomonas*. Of particular focus was the distribution between pyrenoid and thylakoid subcellular compartments. The authors also performed mathematical modeling of the fluxes and estimated kinetic and transport rates between the compartments.

What is new about this work? My general assessment is that not much is new and what is new is not that surprising. The localization of the entire set of CBC enzymes is new, but most enzymes were found to be restricted to the stroma of the thylakoid. The results support what was previously known from other studies. Since Rubisco is known to be in both locations, it is obvious that the substrate and products of this enzyme will have to exchange between the compartments.

1\) I don\'t think the kinetic modeling will give correct information because it is lacks important known regulation (i.e. allostery, light) and is not parameterized with enough data. For estimating more parameters (65 k values and 40 diffusion constants) from steady-state measurements of 11 total metabolite concentrations and 12 enzymes under 2 conditions, which by my calculations is 46 measurements.

2\) The lack of statistical agreement for 6/16 metabolites, suggests the model (or the measurements) is wrong. Therefore, I don\'t understand why one would trust in the results from the model.

Once the experimental results of localization are known, I don\'t understand why the modeling would include transport reactions of all intermediates and enzymes in both locations. The modeling effort could be more focused if the subcellular experiments were first used as constraints, which would eliminate lots of transport and kinetic parameters.

The thermodynamic analysis while correct didn\'t provide much insight. What is the significance of two enzymes having a positive ∆G? In panel A, TPI has a positive ∆G. I think for a reversibility analysis in vivo metabolic flux analysis by 13C would be more informative.

The analysis of diffusion between compartments is important, but is rather unclear. In the subsection "Mechanisms of metabolite transport between microcompartments", what is the estimated concentration gradient (it seems you give this in the fourth paragraph of the Discussion on the order of 24 or 8 nM)? Given a reasonable estimate for diffusivity of small molecules in water, is diffusion feasible to support the flux? I question the logic in the aforementioned paragraph. Just because concentrations go downhill doesn\'t rule out facilitated transport (i.e. not bulk diffusion), but the converse would be true (i.e. uphill requires expenditure of cellular energy). For example, one normally starts a microbial culture with 30g/L of glucose (160 mM), the intracellular concentration is certainly lower than this, but it doesn\'t mean diffusion is sufficient to explain the results! Certainly facilitated transport is needed to pass through the plasma membrane. The authors get the point of facilitated transport correct in the Discussion, but the results can be improved.

The conclusion that transport is tightly regulated is a flawed conclusion. Your modeling effort enforces a steady-state, so of course the export rate of 3PGA would have to balance the import of RuBP by a factor of 2. You are proving what you assume. Where is the evidence of regulation, particularly of transport?

10.7554/eLife.37960.sa2

Author response

> Essential revisions:
>
> 1\) There are issues surrounding the potential localization and quantification of this partitioning for Rubisco that need to be discussed/tested depending on how the study was conducted.

We added a whole paragraph (subsection "Distribution of Calvin-Benson cycle enzymes", last paragraph) to the Results section dealing with Rubisco localization. We also want to stress that our interpretation of the two models focusses on the differences of non-CCM and CCM-induced conditions and these differences in Rubisco localisation were found under all experimental set-ups and with both techniques (enzyme activity measurement of pyrenoid-enriched fraction and fluorescence analysis).

> 2\) Better clarity on how fractional metabolite levels were estimated.

We did this by clarifying the Results (subsection "Metabolites in high-CO~2~ grown (HC) cells, and in low-CO~2~ grown cells after 15 min of exposure to 5% CO~2~ (LC\*)), Discussion (first paragraph) and Materials and methods section (subsection \"Metabolite measurements by HPLC-MS/MS" and subsection "Model parameterization", last paragraph). We also improved the legend of Figure 2 and refer more often to the Supplementary file 1D (subsection "Metabolites in high-CO~2~ grown (HC) cells, and in low-CO~2~ grown cells after 15 min of exposure to 5% CO~2~ (LC\*)", first paragraph), where all the numbers are given and the reader can directly retrace our normalisation for example by recalculation.

> 3\) There was concern that the lack of allosteric factors in the model was creating the lack of fitting on specific metabolites. This potential hindrance of the model should be discussed and the potential role of this in limiting the model fit should be commented upon.

Our detailed opinion on this issue is given as response to reviewer 3 (below). We also emphasized in the text that we used part of the experimental data to reduce the number of parameters of the model already and were therefore able to construct a very reliable, well-fitted model.

> Reviewer \#1:
>
> \[...\] The authors measure Rubisco activity in fractions enriched in pyrenoid and stromal proteins and find differences in the activity in both fractions that change in their ratio, depending on the CO~2~ level (Figure 2). The authors write that more than 60% of Rubisco is in the pyrenoid in LC cells (ambient CO~2~ level) and about 20% in HC cells (5% CO~2~ level). Then, they perform immunolocalization studies with Venus-fusion constructs (Figure 3). To my mind, the results shown in Figure 3 contradict the former findings of the authors. The small Rubisco subunits RBCS1 and RBCS2 are only visible in the pyrenoid and not in the other parts of the chloroplast, including the stroma. Unfortunately, the authors do not mention if the used cells were grown under LC or HC for these experiments. In any case, a certain portion of Rubisco should be distributed over the chloroplast stroma if Rubisco is present to a significant extent in the stroma, and the results are not an artifact of an impure stromal fraction. The stromal fraction was obtained by lysis of the cells and a centrifugation step using the resulting supernatant. I am afraid that this fraction may be contaminated with pyrenoid proteins that derive from partial lysis of the pyrenoid when disrupting the cells. Figure 1A in Mackinder et al. (2016), to which the authors refer, shows parts of pyrenoids as well, being in agreement with this possibility. An alternative would be that the fusion construct is not reflecting the real localization pattern of the smaIl Rubisco subunits. I suggest that the authors clarify this important step by conducting immunolocalization experiments with cells grown at LC and HC using anti-Rubisco antibodies before they draw their final conclusions. Especially under HC, it should be visible that the Rubisco is not only present in the pyrenoid but also in the rest of the plastid.

We understand the reviewer's concern and added a whole paragraph (subsection "Distribution of Calvin-Benson cycle enzymes", last paragraph) to the Results section to deal with the, at first sight, contracting results of enzyme activity measurements and the fluorescence analysis. We also added the growth conditions to the Results section (subsection "Distribution of Calvin-Benson cycle Enzymes", third paragraph) and the legend of Figure 3, and added three paragraphs to the Materials and methods section (subsections "Enzymatic activities", "Proteomics data" and "Protein Localization") for more details.

We want to point out that the mentioned Figure 1A of Mackinder et al. (2016) indeed shows TEMs of pyrenoids and parts of pyrenoids. However, these sections were taken from the pellet fraction (the pyrenoid-enriched fraction) not the supernatant fraction.

> Another critical point is that the authors change the CO~2~ treatment conditions when performing the metabolites studies. In the latter case, they use LC cells that have been treated for 15 min with 5% CO~2~ before harvesting. Their reasons are understandable, but it would be desirable to have the same conditions for the protein and metabolites studies.

Figure 2---figure supplement 1 shows that the physiology of the pyrenoid was not affected by the 15 min high CO~2~ exposure. Also, the transcriptome study of a shift from HC to LC by Brueggeman et al. (2012) found major changes of the transcriptome later than 30 min after the shift. To our knowledge, there is no indication that the shift from LC to HC is faster than this.

Brueggeman AJ, Gangadharaiah DS, Cserhati MF, Casero D, Weeks DP, Ladunga I (2012) Activation of the carbon concentrating mechanism by CO~2~ deprivation coincides with massive transcriptional restructuring in *Chlamydomonas reinhardtii*. Plant Cell 24: 1860-1875

> In summary, this is an interesting and highly important topic and the manuscript should be of interest to a broad readership. However, the authors have to address the mentioned concerns to either verify their conclusion or to change it and consequently adapt their model.

Thanks a lot, we clarified our conclusion and methods.

> Reviewer \#2:
>
> \[...\] In my opinion the authors should address two issues near the beginning of the Discussion. The most serious issue relates to the estimation of metabolite concentrations. If I understand the methods correctly, the authors have quantitated the metabolite amount in the entire cell and have not tried to determine the metabolite amounts in the chloroplast versus cytoplasm. If that is true, it is not clearly stated in the beginning of the Discussion. How were chloroplast CBC metabolite levels estimated if the measured amount of each metabolite was for the entire cell? The authors need to say exactly what assumptions they used to calculate the amount of the metabolite in the stroma. The only place this was addressed was in the legend to Figure 2. It should be in the Materials and methods section and reiterated at the beginning of the discussion.

We added more information of the normalization of the metabolite concentration in the Results section (subsection "Metabolites in high-CO~2~ grown (HC) cells, and in low-CO~2~ grown cells after 15 min of exposure to 5% CO~2~ (LC\*)) and clarified the beginning of the Discussion (first paragraph). Also, more details are given in the legend of Figure 2 and in the Materials and methods section (subsection \"Metabolite measurements by HPLC-MS/MS").

Additionally, the concentration of metabolites estimated from the modelling were compared to the concentration of metabolites in the chloroplast calculated based on whole cell measurements. In order to compare subcompartment-specific concentrations predicted by the model and calculated chloroplast concentrations, we used the sum of predicted stroma and pyrenoid concentration. We added a sentence to the Materials and methods section (subsection "Model parameterization", last paragraph) to make this clear as well.

> My second concern was which value for the percentage of Rubisco in the pyrenoid was used? Clearly the 60% pyrenoid localization seen in fractionation is lower than earlier estimates using immunogold or the fluorescence measurements. Again at the beginning of the model description and in the discussion the actual values used should be stressed. From Figure 1 it would appear that the value used was 100% in the pyrenoid but I am not certain. I think any value over 90% is reasonable but the authors should state why they favored the fluorescence method or literature values over the MS or activity measurements. I suspect there is some dissolution of the pyrenoid and that is what accounts for the discrepancy but it should be noted.

For model parametrization we wanted to use values coming from the same study and therefore, an average of 61.8% pyrenoid localization of Rubisco under LC as measured in this study was used. The added paragraph (subsection "Distribution of Calvin-Benson cycle enzymes") discusses the possibility of dissolution.

The actual values were added to the text in the Results (subsection "Distribution of Calvin-Benson cycle enzymes", last paragraph and subsection "Modelling the", fifth paragraph) and the Discussion (first paragraph) section.

> Reviewer \#3:
>
> \[...\] What is new about this work? My general assessment is that not much is new and what is new is not that surprising. The localization of the entire set of CBC enzymes is new, but most enzymes were found to be restricted to the stroma of the thylakoid. The results support what was previously known from other studies. Since Rubisco is known to be in both locations, it is obvious that the substrate and products of this enzyme will have to exchange between the compartments.
>
> 1\) I don\'t think the kinetic modeling will give correct information because it is lacks important known regulation (i.e. allostery, light) and is not parameterized with enough data.

We agree with the reviewer that mass action may not be the most realistic enzyme kinetics, however, in absence of information about the kinetic form of the flux (e.g. Michaelis-Menten, power law, or other special form) and to allow for a systematic investigation, we aimed to focus on the most mathematically tractable approach, hence the usage of mass action kinetic.

In addition, every reaction is split into its elementary reactions, which includes the direct effect of enzymes. Therefore, the approach can account for variable reaction rates across different conditions due to changes in enzyme concentrations.

Furthermore, we would like to point out that there are examples of well-studied highly regulated metabolic processes (e.g. the Calvin-Benson cycle) which can be accurately modelled by mass action kinetic (with apparent rate constants, see comprehensive model comparison of Arnold and Nikoloski (2011, Trends in Plant Science).

> For estimating more parameters (65 k values and 40 diffusion constants) from steady-state measurements of 11 total metabolite concentrations and 12 enzymes under 2 conditions, which by my calculations is 46 measurements.

To reduce the number parameters estimated we used the information about enzyme localization. Based on the experimental data we reduced the number of diffusion constants from 40 to 2. In addition, the number of reactions in pyrenoid is adapted,for example in the scenario were Rubisco is the only enzyme in the pyrenoid, diffusion is allowed for RuBP and PGA only. We added a sentence to the subsection "Modelling the effect of chloroplast microcompartmentation on the CBC" to make this clear.

> 2\) The lack of statistical agreement for 6/16 metabolites, suggests the model (or the measurements) is wrong. Therefore, I don\'t understand why one would trust in the results from the model.

We do not agree with the reviewer's comment that the model is wrong. Model fit is usually validated based on the overall chi square value, which provided significant fit for the samples analysed. Therefore, we are convinced that our model is suited to be used for hypothesis testing.

Individual chi square values were calculated since we wanted to know which metabolites fit better or worse and if these metabolites have a particular role in the modelled processes.

Indeed, we found the metabolites involved in reactions for which it is known that they do not follow mass action kinetics not to fit well. Nevertheless, we would like to stress that the overall model fits were statistically significant.

We hope the reviewer agrees that for the question of interest an overall fit between model predictions and measurements is sufficient.

> Once the experimental results of localization are known, I don\'t understand why the modeling would include transport reactions of all intermediates and enzymes in both locations. The modeling effort could be more focused if the subcellular experiments were first used as constraints, which would eliminate lots of transport and kinetic parameters.

As suggested by the reviewer, we indeed used the experimental data to reduce the number of model reactions and updated the text to make this clear.

> The thermodynamic analysis while correct didn\'t provide much insight. What is the significance of 2 enzymes having a positive ∆G? In panel A, TPI has a positive ∆G. I think for a reversibility analysis in vivo metabolic flux analysis by 13C would be more informative.

We thank the reviewer for recognizing this point. We updated the text accordingly (subsection "Two modes of CBC operation").

> The analysis of diffusion between compartments is important, but is rather unclear. In the subsection "Mechanisms of metabolite transport between microcompartments", what is the estimated concentration gradient (it seems you give this in the fourth paragraph of the Discussion on the order of 24 or 8 nM)? Given a reasonable estimate for diffusivity of small molecules in water, is diffusion feasible to support the flux? I question the logic in the aforementioned paragraph.

We added the values to make the difference directly visible (subsection "Mechanisms of metabolite transport between microcompartments").

> Just because concentrations go downhill doesn\'t rule out facilitated transport (i.e. not bulk diffusion), but the converse would be true (i.e. uphill requires expenditure of cellular energy). For example, one normally starts a microbial culture with 30g/L of glucose (160 mM), the intracellular concentration is certainly lower than this, but it doesn\'t mean diffusion is sufficient to explain the results! Certainly facilitated transport is needed to pass through the plasma membrane. The authors get the point of facilitated transport correct in the Discussion, but the results can be improved.

We agree with the reviewer that a downhill concentration gradient does not directly mean diffusion and therefore, we updated the text accordingly.

We improved the usage of diffusion in the Results section (subsection "Mechanisms of metabolite transport between microcompartments").

> The conclusion that transport is tightly regulated is a flawed conclusion. Your modeling effort enforces a steady-state, so of course the export rate of 3PGA would have to balance the import of RuBP by a factor of 2. You are proving what you assume. Where is the evidence of regulation, particularly of transport.

The reviewer is correct, this observation is trivial and therefore, we opted to remove this sentence.
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